SG Americas Securities, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$694
+402.9%
21,549
+188.8%
0.01%
+300.0%
Q4 2022$138
-100.0%
7,462
-34.6%
0.00%
-50.0%
Q3 2022$308,000
-67.4%
11,402
-66.4%
0.00%0.0%
Q3 2021$946,000
+332.0%
33,961
+360.0%
0.00%
+300.0%
Q2 2021$219,000
-44.0%
7,383
-47.2%
0.00%
-50.0%
Q1 2021$391,000
+191.8%
13,993
+195.3%
0.00%
+100.0%
Q4 2020$134,000
-89.1%
4,738
-90.3%
0.00%
-87.5%
Q3 2020$1,234,000
+100.3%
49,081
+94.5%
0.01%
+60.0%
Q2 2020$616,000
+321.9%
25,230
+155.6%
0.01%
+400.0%
Q1 2020$146,000
+13.2%
9,870
+24.5%
0.00%0.0%
Q4 2019$129,000
-25.4%
7,926
-27.8%
0.00%
-50.0%
Q1 2019$173,000
+20.1%
10,981
+109.9%
0.00%
+100.0%
Q3 2017$144,000
-35.1%
5,231
-51.3%
0.00%
-50.0%
Q4 2016$222,000
+73.4%
10,734
+46.0%
0.00%
+100.0%
Q1 2016$128,000
+21.9%
7,351
+123.4%
0.00%0.0%
Q2 2015$105,0003,2910.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders